Indication
Recurrent Unexplained Implantation Failure
1 clinical trial
2 products
Clinical trial
Efficacy of Certolizumab in Women With Unexplained Recurrent Implantation Failure: a Double-blind Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2029-04-01
Product
CertolizumabProduct
Placebo